NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

UCB SA (BR: UCB)

 
UCB Technical Analysis
1
As on 10th Jul 2024 UCB STOCK Price closed @ 145.00 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

UCBSTOCK Price

Open 143.70 Change Price %
High 145.00 1 Day N/A N/A
Low 142.95 1 Week 0.00 0.00
Close 145.00 1 Month 0.00 0.00
Volume 137785 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
BR Belgium Most Active Stocks
BOTHE 0.29 70.59%
ABI 55.52 %
ACPH 0.89 0.00%
KBC 67.44 %
UMI 13.54 %
AGS 43.60 %
PROX 7.65 %
SOLB 32.04 %
BPOST 2.64 %
WDP 25.96 %
 
BR Belgium Top Gainers Stocks
BOTHE 0.29 70.59%
ANT 6.41 3.22%
ANT 6.41 3.22%
WOLS 4.91 2.29%
REC 11.16 1.82%
REC 11.16 1.82%
REC 11.16 1.82%
GLOG 4.90 0.82%
GLOG 4.90 0.82%
SAB 27.26 0.52%
 
BR Belgium Top Losers Stocks
BELR 1.93 -74.27%
BELR 1.93 -74.27%
NEWT 1.80 -9.55%
NEWT 1.80 -9.55%
PIC 66.00 -6.25%
PIC 66.00 -6.25%
PIC 66.00 -6.25%
BEFB 46.10 -2.54%
TERB 93.00 -1.48%
BALTA 1.36 -1.45%
 
 
UCB
Daily Charts
UCB
Intraday Charts
Whats New @
Bazaartrend
UCB
Free Analysis
 
UCB Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
UCB Forecast July 2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
UCB Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
UCB Forecast2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
UCB Other Details
Segment EQ
Market Capital 18890641408.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
UCB Address
UCB
 
UCB Latest News
 
Your Comments and Response on UCB SA
 
UCB Business Profile
UCB SA, a biopharmaceutical company, develops therapies and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, nayzilam, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; bimekizumab for treating psoriasis, psoriatic arthritis, axial spondyloarthritis, and hidradenitis suppurativa; and dapirolizumab pegol for systemic lupus erythematosus. In addition , the company is involved in developing padsevonil for the treatment of drug-resistant epilepsy; rozanolixizumab to treat myasthenia gravis, immune thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy; zilucoplan to treat myasthenia gravis immune-mediated necrotizing myopathy; staccato alprazolam to treat active epileptic seizure; and UCB0107 to treat tauopathies and progressive supranuclear palsy. Further, it engages in contract manufacturing activities. The company has a multi-year collaboration agreement with Stanford Medicine to enhance patient value for people living with severe diseases. UCB SA has collaboration agreements with Sanofi, Amgen, Biogen, Otsuka, and doc.ai. The company operates in the United States, Japan, Germany, rest of Europe, Spain, France, Italy, the United Kingdom, Ireland, China, Belgium, and internationally. The company was founded in 1928 and is headquartered in Brussels, Belgium. Address: AllEe de la Recherche, 60, Brussels, Belgium, 1070
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service